CANTOS Trial: Canakinumab Reduces MACE and Mortality Among CKD Patients

Sadaf Sharfaei, M.D.
0 Min Read

Dr. Ridker and Dr. C. Michael Gibson

Subscribe on iTunes or Google Play.

Share This Article
Leave a Comment

Leave a Reply